(RTTNews.com) – Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) Tuesday said it aims to achieve further growth in the coming years and is seeking higher sales and earnings in all businesses. The company said it has set ambitious aspirations being optimistic about its medium-term development.
Management Board Chairman Werner Baumann
said at the “Meet Management” investor conference in Cologne that the company expects especially significant sales and margin growth at Pharmaceuticals. The forecast is based on the positive development of recently launched products, for which combined peak sales potential is more than 10 billion euros.
At Crop Science, Bayer expects a substantial increase in the margin after closing of the planned acquisition of Monsanto. The prospects for Consumer Health and Animal Health are positive as well.
For comments and feedback: contact editorial@rttnews.com
Plantations International